Science 37 Accelerates Clinical Trial Enrollment

The Challenge: Scaling Under Operational Strain

By late 2022, Science 37's in-house medical records team was growing quickly. At its peak, the team included 13 staff managing manual record requests, provider follow-ups, and intake review processes. But the volume and complexity of studies made scaling this model unsustainable.

Compounding the issue, delays in retrieving patient records slowed enrollment cycles and sometimes led to missed trial opportunities. Record retrieval turnaround times averaged 1–2 weeks, with some extreme cases stretching to 60+ days.

“We were doing all of the work that Predoc would do with a 13-person in-house team. We just couldn't keep up.”

Joanna Freitag

Director, Medical Records, Science 37

The Solution: Outsourcing Records Retrieval to Predoc

In 2023, Science 37 piloted Predoc to offload chart chase and streamline data acquisition. The results were immediate: in-house team size reduced by 70%, from 13 to 4 FTEs. Record turnaround times were cut in half, with many records returned same-day or within 4 days. The partnership provided ongoing, scalable support for complex studies requiring high volumes of records.

“Using Predoc gave us the scalability we needed and freed up our team to focus on patient follow-ups, getting more records back overall.”

Joanna Freitag

Director, Medical Records, Science 37

The Impact: Faster Enrollment, Better Throughput

While study timelines vary, Science 37 reported that time to consent has decreased by 50%, significantly improving trial throughput.

The results were clear: faster throughput meant that by 2025, Science 37 became the number one recruiting site in the country for at least one study. Rare disease studies, which previously struggled to hit recruitment goals, were no longer a challenge.

“Whether the patient is a yes or a no, we're getting to that answer faster. We can screen more people and reach those yeses quicker.”

Jeff Richardson

SVP Operations, Science 37

Predoc as Part of Science 37's DNA

As Science 37 continues to pitch trial sponsors, they're incorporating Predoc as part of their operations — offering faster data access, better patient throughput, and improved trial efficiency.

“Predoc lets us show sponsors that we can move quickly and scale. It's not just a vendor — it's part of the value proposition.”

Jeff Richardson

SVP Operations, Science 37